1. European Medicines Agency. European Medicines Agency 2011 priorities for drug safety research: patient health protection. 2010. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/07/WC500094267.pdf. [Accessed June 20, 2011].
2. Food and Drug Administration. Postmarketing drug safety information for patients and providers: long acting beta agonists. 2010. Available from: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm108111.htm. [Accessed February 4, 2011].
3. National Heart, Lung and Blood Institute. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma. 2007. Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. [Accessed June 5, 2011].
4. Food and Drug Administration. Safety information: long-acting beta-agonists (LABAs): new safe use requirements. 2011. Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm201003.htm. [Accessed June 11, 2011].
5. British Thoracic Society & Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. 2009. Available from: http://www.brit-thoracic.org.uk. [Accessed March 13, 2011].